Equivalence of St John's wort extract (Ze 117) and fluoxetine: A randomized, controlled study in mild-moderate depression

International Clinical Psychopharmacology

Volumn 15, Issue 2, 2000, Pages 61-68

  Schrader, E ^a  

^a Praxis Klinische A   (Germany)

Author keywords

Double blind randomized trial; Hypericum; Mild moderate depression; St John's wort; Ze 117

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGITATION; ANXIETY NEUROSIS; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; ERECTILE DYSFUNCTION; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HAMILTON SCALE; HUMAN; HYPERICUM PERFORATUM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NERVOUSNESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTIGO; VOMITING;

EID: 0034008572     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200015020-00001     Document Type: Article

References (32)

1. Abt K (1987) Descriptive data analysis: a concept between confirmatory and exploratory data analysis. Meth Inform 26:77-88.
2. Angst J, Bech P, Boyer P (1989) Consensus on the methodology of clinical trials of antidepressants, Zurich, March 1988: report of the consensus committee. Pharmacopsychiatry 22:3-7.
3. Bladt S, Wagner H (1994) Inhibition of MAO by fractions and constituents of Hypericum extract. J Geriatr Psychiatr Neurol 7 (Suppl. 1):S57-S59.
4. Chatterjee SS, Bhattacharya SK, Wonnemann M, Singer A, Müller WE (1998) Hyperforin as a possible antidepressant component of hypericum extracts. Life Sci 63:499-510.
5. De Smet PA, Molen WA (1996) St John's wort as an antidepressant. BMJ 313:241-242.
6. Deutsche Arzneimittel (1991) Codex 1986: Johanniskraut - Hyperici herba. DAC 3 (Suppl.):1-5.
7. EC Guidelines (1989) Good Clinical Practice. Medical Directive for Drugs in the European Community. Volume III, pp. 115-132.
8. Fähndrich E, Linden M (1982) Zur rehabilität und validität der stimmungsmessung mit der visuellen analog-skala (VAS) [The validity and reliability of the visual analogue mood scale]. Pharmacopsychiatry 15:90-94.
9. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatr 23:56-62.
10. Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278-296.
11. Harrer G, Hübner WD, Podzuweit H (1994) Effectiveness and tolerance of the hypericum extract LI160 compared with maprotiline: a multicentre double-blind study. J Geriatr Psychiatr Neurol 1 (Suppl. 1):S24-S28.
12. Hartung J, Elpelt B, Klösener KH (1987) Statistik Lehrund Handbuch der Angewandten Statistik [Statistics, textbook and handbook of applied statistics]. München Wien, Oldenbourg: R. Verlag.
13. ICH (1997) Notes For Guidance On Good Clinical Practice. Topic E6 1/17/1997. Location: ICH.
14. Laakman G, et al. (1998) St John's wort in mild to moderate depression: the relevance of Hyperforin for the clinical efficacy. Pharmacopsychiatry 31 (Suppl. 1);54-59.
15. Linde K, Ramirez G, Mulrow CD (1996) St John's Wort for depression - an overview and metaanalysis of randomised clinical trials. Br Med J 313:253-258.
16. Müller WEG, Rossol R (1993) Einfluβ von Hypericum-extrakt auf die expression von serotonin-rezeptoren [Effect of Hypericum extract on the expression of serotonin receptors]. Nervenheilkunde 12:357-358.
17. Müller WE, Singer A, Wonnemann M, Hafner U, Rolli M, Schäfer C (1998) Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry 31 (Suppl.):16-21.
18. National Institute of Mental Health (1976) 028 CGI Clinical Global Impressions. In: ECDEU Assessment for Psychopharmacology, rev. edn (Guy W, ed.), Rockville, MD: NIMH, pp. 217-222.
19. Neary JT, Bu Y (1999) Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes. Brain Res 816:358-363.
20. Noether GE (1987) Sample size determination for some common nonparametric tests. J Am Stat Assoc 82:645-647.
21. Raffa RB (1998) Screen of receptor and uptake-site activity of hypericin component of St John's wort reveals sigma receptor binding. Life Sci 62:L265-L270.
22. Schrader E, Meier B, Brattstrom A (1998) Hypericum treatment of mild-moderate depression in a placebo-controlled study: a prospective, double-blind, randomized, placebo-controlled, multicentre study. Hum Psychopharmacol 13:163-169.
23. Thiede H-M, Walper A (1993) MAO-und COMT-Hemmung durch Hypericum-extrakte und Hypericin [MAO-and COMT inhibition by Hypericum extracts and hypericin]. Nervenheilkunde 12:346-348.
24. Thiede HM, Walper A (1994) Inhibition of MAO and COMT by Hypericum extracts and hypericin. J Geriatr Psychiatr Neurol 1 (Suppl. 1):S54-S56.
25. Thiele B, Brink I, Ploch M (1994) Modulation of cytokine expression by Hypericum extract. J Geriatr Psychiatr Neurol 7 (Suppl. 1):S60-S62.
26. Upton R (1997) St John's wort. American Herbal Pharmacopoeia and Therapeutic Compendium. Location: publisher? pp. 1-32.
27. Volz HP (1997) Controlled clinical trials of hypericum extracts in depressed patients - an overview. Pharmacopsychiatiy 30 (Suppl.):72-76.
28. Vorbach EU, Hübner WD, Arnoldt KH (1994) Effectiveness and tolerance of the hypericum extract LI160 in comparison with imipramine: randomised double-blind study in 135 outpatients. J Geriat Psychiatr Neurol 7 (Suppl. 1):S19-S23.
29. Wheatley D (1997) LI160, an extract of St John's wort versus amitriptyline in mildly to moderately depressed outpatients - a controlled 6-week clinical trial. Pharmacopsychiatry 30 (Suppl.):77-80.
30. Wheatley D (1998) Hypericum extract. CNS Drugs 9:431-440.
31. Wheatly D, Smith D, eds (1997) Psychopharmacology of Cognitive and Psychiatric Disorders in the Elderly. London: Chapman and Hall.
32. Witte B, Harrer G, Kaptan T, Podzuweit H, Schmidt U (1995) Treatment of depression with a highly concentrated hypericum preparation: a multi-centred, placebo-controlled, double-blind study. Forschr Med 113:404-408.